Verdence Capital Advisors’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42K | Buy |
19,178
+69
| +0.4% | +$151 | ﹤0.01% | 666 |
|
|
2025
Q1 | $26K | Hold |
19,109
| – | – | ﹤0.01% | 647 |
|
|
2024
Q4 | $25.4K | Hold |
19,109
| – | – | ﹤0.01% | 631 |
|
|
2024
Q3 | $22.2K | Hold |
19,109
| – | – | ﹤0.01% | 638 |
|
|
2024
Q2 | $25.4K | Hold |
19,109
| – | – | ﹤0.01% | 590 |
|
|
2024
Q1 | $37.6K | Hold |
19,109
| – | – | ﹤0.01% | 584 |
|
|
2023
Q4 | $26.9K | Hold |
19,109
| – | – | ﹤0.01% | 565 |
|
|
2023
Q3 | $24.7K | Hold |
19,109
| – | – | ﹤0.01% | 555 |
|
|
2023
Q2 | $32.9K | Hold |
19,109
| – | – | ﹤0.01% | 530 |
|
|
2023
Q1 | $34.6K | Hold |
19,109
| – | – | ﹤0.01% | 531 |
|
|
2022
Q4 | $50.8K | Hold |
19,109
| – | – | 0.01% | 490 |
|
|
2022
Q3 | $63K | Hold |
19,109
| – | – | 0.01% | 510 |
|
|
2022
Q2 | $70K | Hold |
19,109
| – | – | 0.01% | 503 |
|
|
2022
Q1 | $97K | Buy |
+19,109
| New | +$97K | 0.01% | 501 |
|